Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2021

Month: January

Request Number: A-2019-001863

Request Summary: Adverse Reaction Report (AER) for DEXILANT. Report numbers: E2B_02819319. AERs for ENTYVIO: E2B_02862257, E2B_02839118, 000731529, 000731158, E2B_02854153. AERs for VEDOLIZUMAB: E2B_02822017, E2B_02853524, E2B_02818273, E2B_02858723, E2B_02862064. AERs for ONDANSETRON: E2B_02829961, E2B_02829775, E2B_02841655, E2B_02861229, E2B_02826331, E2B_02837423, E2B_02860174, E2B_02861363, E2B_02861422, 000732064. AERs for PANTOPRAZOLE SODIUM: E2B_02820518, E2B_02837630, E2B_02820515, E2B_02829485, E2B_02819368. AERs for PANTOPRAZOLE: E2B_02820525, E2B_02821183, E2B_02851827, E2B_02831379, E2B_02835873, E2B_02855598, E2B_02865069, 000732053, E2B_02838948, E2B_02832091, 000731504, E2B_02828986, 000731073. AERs for TECTA: E2B_02861566, E2B_02856303. AER for PANTOPRAZOLE MAGNESIUM: E2B_02821386.

Disposition: Disclosed in part

Number of pages: 852

Date modified: